Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Opioid Manufacturers Teva and Allergan Face Insurance Fraud Charges : Risk & Insurance
Raoul, colleagues reach $6.6 billion settlement with Teva, Allergan over role in opioid epidemic - Health News Illinois
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/LCGCPK3EYBF3PJZYOYFN26JDWQ.jpg "Teva buying Allergan, drops Mylan bid")
Teva buying Allergan, drops Mylan bid
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Teva Completes Acquisition of Actavis Generics | Business Wire
Teva deal lets us double down on brands: Allergan CEO
What Exactly Did Allergan and Teva Sell to Impax? - TheStreet
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suits - The New York Times
teva
Cipla, Glenmark in race for hived-off Teva-Allergan generics in US, Health News, ET HealthWorld
Teva, Allergan reach $161.5 mln opioid settlement with West Virginia | Reuters
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva Can Benefit by Acquiring Allergan Generics
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva buys Allergan's generic drug unit for $40.5B
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
San Francisco reaches $58 mln opioid settlement with Teva, Allergan | Reuters
New York State Accuses Teva and Allergan With Insurance Fraud Over Opioid Claims - Equities News
